Cargando…
Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children
Transplant-associated thrombotic microangiopathy (TA-TMA) and sickle cell disease (SCD) share features of endothelial and complement activation. Thus, we hypothesized that SCD is a risk factor for TA-TMA and that prehematopoietic cellular transplantation (HCT) markers of endothelial dysfunction and...
Autores principales: | Schoettler, Michelle, Stenger, Elizabeth, Spencer, Kathleen, Lutterman, Deborah, Rumbika, Savanah, Jones, Jayre, Haight, Ann, Parikh, Suhag, Qayed, Muna, Watkins, Benjamin, Krishnamurti, Lakshmanan, Williams, Kirsten M., Chonat, Satheesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164784/ https://www.ncbi.nlm.nih.gov/pubmed/36075028 http://dx.doi.org/10.1182/bloodadvances.2022008058 |
Ejemplares similares
-
Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure
por: Stenger, Elizabeth O., et al.
Publicado: (2023) -
Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease
por: Chonat, Satheesh, et al.
Publicado: (2020) -
Acute GVHD, BK virus hemorrhagic cystitis and age are risk factors for transplant-associated thrombotic microangiopathy in adults
por: Vasu, Sumithira, et al.
Publicado: (2022) -
Rejection-associated Phenotype of De Novo Thrombotic Microangiopathy Represents a Risk for Premature Graft Loss
por: Petr, Vojtech, et al.
Publicado: (2021) -
Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation
por: Janardan, Sanyukta, et al.
Publicado: (2022)